Cancer Screening

In this episode, Guido Baechler discusses the pandemic’s impact on healthcare and preventative health, personalizing cancer care after diagnosis and more.

Widespread reductions in cancer screenings during the COVID-19 pandemic may be associated with delayed cancer diagnoses and increased mortality for breast, cervical and colon cancers, according to study results published in JAMA Oncology.

Colorectal cancer screening prevalence remained low in 2018 among U.S. adults aged 50 to 54 years vs. 70 to 75 years, with the younger group exhibiting larger disparities by race/ethnicity, education level, income and insurance.

CHICAGO — Just 18% of women experiencing homelessness who were eligible underwent a mammography over a 5-year period, according to research presented at ASCO Annual Meeting.

CHICAGO – Advanced procedures such as suturing and cryosurgery will define a successful optometric practice in the future, Rich Castillo, OD, DO, said at Optometry’s Meeting.

CDC researchers said they did not find a recent increase in cases of hepatitis or adenovirus types 40/41 among children in the United States compared with pre-pandemic baseline levels.

Black women had an increased risk for not undergoing biopsy within 90 days after abnormal screening mammography results compared with women of other racial and ethnic groups, according to study results published in JAMA Oncology.

Angela M. Nicholas, MD, says that no patient she sees aged older than 45 years leaves her office without discussing cancer screening.

Recent findings suggest that with HPV tests, intervals between cervical screenings can be extended to 5 years after a negative result in women aged 25 to 49 years and even longer for women aged older than 50 years.

The percentage of patients presenting with late-stage breast and colorectal cancers increased between 2019 and 2020 at Moores Cancer Center at University of California San Diego Health, according to data published in JAMA Network Open.